Mutations in Envelope gp120 Can Impact Proteolytic Processing of the gp160 Precursor and Thereby Affect Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Pseudoviruses

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  2007-09-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01215-07PMID 17855534PMCID PMC2169095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1.

  2007cited by this paper
• Macaques Infected with a CCR5-Tropic Simian/Human Immunodeficiency Virus (SHIV) Develop Broadly Reactive Anti-HIV Neutralizing Antibodies

  2007cited by this paper
• Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.

  2007cited by this paper
• Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.

  2007cited by this paper
• A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.

  2007cited by this paper
• Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.

  2006cited by this paper
• Distribution and three-dimensional structure of AIDS virus envelope spikes

  2006cited by this paper
• Impact of Natural Polymorphism within the gp41 Cytoplasmic Tail of Human Immunodeficiency Virus Type 1 on the Intracellular Distribution of Envelope Glycoproteins and Viral Assembly

  2006cited by this paper
• A Mutation in the Human Immunodeficiency Virus Type 1 Gag Protein Destabilizes the Interaction of the Envelope Protein Subunits gp120 and gp41

  2006cited by this paper
• Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques

  2006cited by this paper
• Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1

  2006cited by this paper
• The production of cleaved, trimeric human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein vaccine antigens and infectious pseudoviruses using linear polyethylenimine as a transfection reagent.

  2006cited by this paper
• Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles

  2005cited by this paper
• An Unrelated Monoclonal Antibody Neutralizes Human Immunodeficiency Virus Type 1 by Binding to an Artificial Epitope Engineered in a Functionally Neutral Region of the Viral Envelope Glycoproteins

  2005cited by this paper
• Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1

  2005influential reference
• Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1

  2005cited by this paper
• Structure of an unliganded simian immunodeficiency virus gp120 core

  2005cited by this paper
• HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity.

  2005influential reference
• Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage.

  2005influential reference
• Basic Statistical Considerations in Virological Experiments

  2005cited by this paper
• The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.

  2005cited by this paper
• Evolutionary Dynamics of the Glycan Shield of theHuman Immunodeficiency Virus Envelope during Natural Infection andImplications for Exposure of the 2G12Epitope

  2004cited by this paper
• N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies

  2004influential reference
• HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity.

  2004cited by this paper
• MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment

  2004cited by this paper
• Structural Investigation of the HIV‐1 Envelope Glycoprotein gp160 Cleavage Site 3: Role of Site‐Specific Mutations

  2004cited by this paper
• Rapid evolution of the neutralizing antibody response to HIV type 1 infection

  2003cited by this paper
• Nonneutralizing Antibodies to the CD4-Binding Site on the gp120 Subunit of Human Immunodeficiency Virus Type 1 Do Not Interfere with the Activity of a Neutralizing Antibody against the Same Site

  2003cited by this paper
• Concordant Modulation of Neutralization Resistance and High Infectivity of the Primary Human Immunodeficiency Virus Type 1 MN Strain and Definition of a Potential gp41 Binding Site in gp120

  2003cited by this paper
• Multigene DNA prime‐boost vaccines for SHIV89.6P

  2003cited by this paper
• Heterogeneity of Envelope Molecules Expressed on Primary Human Immunodeficiency Virus Type 1 Particles as Probed by the Binding of Neutralizing and Nonneutralizing Antibodies

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003influential reference
• HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

  2002cited by this paper
• The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120

  2002cited by this paper
• Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

  2002influential reference
• Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

  2002cited by this paper
• Furin at the cutting edge: From protein traffic to embryogenesis and disease

  2002cited by this paper
• HIV Type 1 Variants Transmitted to Women in Kenya Require the CCR5 Coreceptor for Entry, Regardless of the Genetic Complexity of the Infecting Virus

  2002cited by this paper
• Precursor processing by kex2/furin proteases.

  2002cited by this paper
• A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers

  2001cited by this paper
• Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses

  2001cited by this paper
• The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

  2001cited by this paper
• Intracellular functions of N-linked glycans.

  2001cited by this paper
• Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1.

  2001cited by this paper
• A Global Neutralization Resistance Phenotype of Human Immunodeficiency Virus Type 1 Is Determined by Distinct Mechanisms Mediating Enhanced Infectivity and Conformational Change of the Envelope Complex

  2000cited by this paper
• Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.

  2000cited by this paper
• A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

  2000cited by this paper
• Processing, Stability, and Receptor Binding Properties of Oligomeric Envelope Glycoprotein from a Primary HIV-1 Isolate*

  2000cited by this paper
• The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.

  2000cited by this paper
• Understanding influenza virus pathogenicity.

  1999cited by this paper
• The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.

  1999cited by this paper
• Vif and the p55Gag Polyprotein of Human Immunodeficiency Virus Type 1 Are Present in Colocalizing Membrane-Free Cytoplasmic Complexes

  1999cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Regulation of Endosome Sorting by a Specific PP2A Isoform

  1998cited by this paper
• Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity

  1998cited by this paper
• A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

  1998cited by this paper
• Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals

  1997cited by this paper
• Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off

  1997cited by this paper
• The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells

  1997cited by this paper
• Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.

  1997cited by this paper
• Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.

  1997influential reference
• The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

  1997influential reference
• HIV‐1 infection of non‐dividing cells: evidence that the amino‐terminal basic region of the viral matrix protein is important for Gag processing but not for post‐entry nuclear import

  1997cited by this paper
• Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies

  1997influential reference
• Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

  1996cited by this paper
• Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions

  1996influential reference
• Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein

  1996cited by this paper
• Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses

  1996cited by this paper
• Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation

  1995cited by this paper
• The ratio of defective HIV-1 particles to replication-competent infectious virions.

  1994cited by this paper
• Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

  1994cited by this paper
• Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein

  1994cited by this paper
• A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1

  1994cited by this paper
• Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

  1994cited by this paper
• Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage.

  1992cited by this paper
• Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins

  1992cited by this paper
• Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60

  1992influential reference
• The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions

  1992cited by this paper
• Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity

  1992cited by this paper
• A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.

  1991cited by this paper
• Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

  1988cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper
• Immunogenicity and Protective Efficacy of Oligomeric Human Immunodeficiency Virus Type 1 gp140

  year unknowncited by this paper

• Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine–Induced Anti-V2 Antibodies Alone

  2021influential citation
• Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans

  2020cites this paper
• Characterisation of HIV-1 subtype C envelope functional determinants of dual infected individuals

  2018influential citation
• HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded

  2017cites this paper
• Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens

  2016cites this paper
• Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides.

  2016cites this paper
• Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.

  2015cites this paper
• Correction: Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA

  2015cites this paper
• Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA

  2014cites this paper
• Characterization of Molecular Correlates of the Chronic Humoral Immune Response: Clues towards Eliciting Broadly Neutralizing Antibodies against HIV

  2014cites this paper
• Critical Amino Acids within the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein V4 N- and C-Terminals Contribute to Virus Entry

  2014cites this paper
• Advances in HIV-1 Assembly and Release

  2013cites this paper
• HIV-1 Envelope Glycoprotein Resistance to Monoclonal Antibody 2G12 Is Subject-Specific and Context-Dependent in Macaques and Humans

  2013cites this paper
• Unraveling the Entry Mechanism of Baculoviruses and Its Evolutionary Implications

  2013cites this paper
• Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression

  2013cites this paper
• Synthesis of Functional and Variable HIV-1 Envelope Glycoproteins

  2013cites this paper
• Evolution of human immunodeficiency virus type 1 clade C envelope V1-V5 region during disease progression in non-human primate model

  2013cites this paper
• Vaccination studies with the mper of HIV-1 gp41 grafted into transmembrane protein of a gammaretrovirus

  2013cites this paper
• Pokeweed Antiviral Protein Increases HIV-1 Particle Infectivity by Activating the Cellular Mitogen Activated Protein Kinase Pathway

  2012cites this paper
• HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug

  2012cites this paper
• Adaptation of HIV-1 Envelope to Macaque Cells and Implications for the Design of Improved Models of HIV/AIDS

  2012cites this paper
• HIV vaccine design based on in vivo evolution of quasispecies envelope proteins

  2012cites this paper
• The neutralization sensitivity of viruses representing human immunodeficiency virus type 1 variants of diverse subtypes from early in infection is dependent on producer cell, as well as characteristics of the specific antibody and envelope variant.

  2012influential citation
• Binding Interactions between Soluble HIV Envelope Glycoproteins and Quaternary-Structure-Specific Monoclonal Antibodies PG9 and PG16

  2011cites this paper
• The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization.

  2011cites this paper
• The Infectious Molecular Clone and Pseudotyped Virus Models of Human Immunodeficiency Virus Type 1 Exhibit Significant Differences in Virion Composition with Only Moderate Differences in Infectivity and Inhibition Sensitivity

  2009cites this paper
• Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection.

  2009cites this paper
• Balancing Reversion of Cytotoxic T-Lymphocyte and Neutralizing Antibody Escape Mutations within Human Immunodeficiency Virus Type 1 Env upon Transmission

  2009cites this paper